GLP-1 Newsroom is your go-to source for breaking news, expert updates, trends, products, and real-world insights on everything related to GLP-1 medications, journeys, and diets.
You can't turn a corner or scroll a social media site without seeing an ad or a post about someone taking GLP-1 meds like Ozempic or Wegovy. Most research shows one in eight people have tried them or is currently on them. Now, a new GLP-1 map shows a state-by-state breakdown of how many people are using these medications.
Tirzepatide is one of the newest GLP-1-based medications to get FDA approval, and it’s changing the conversation around weight loss and metabolic health in a big way. While tirzepatide for weight loss is a big lure, it's also used to treat Type 2 Diabetes and Obstructive Sleep Apnea (OSA).
